The Los Angeles Theatres blog has a full history of the building and more photos. Be sure to check out the snack bar - it's ...

J.P. Morgan analyst Lisa Gill maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $80.00. The company’s shares closed yesterday at $54.03. Gill covers the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

The new voicemail that was added 4-6 weeks back is totally unacceptable and CVS should be embarrassed of themselves. It’s a horrendous disease that came in and negatively infected the system ...

Authorities accused Carlos Sacanell of trading on insider information to make illegal profits off of CVS Health's 2023 ...

CVS Health ( (CVS)) has issued an announcement. CVS Health has made strategic leadership appointments, naming Prem S. Shah as Group President and Steven H. Nelson as President of Aetna. Shah, with ...

Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. The move, effective ...

Operator Good morning and thank you all for attending the CVS Health third-quarter 2024 earnings call and webcast. My name is ...

During her time at the helm of CVS Health, former chief executive Karen Lynch often placed her complicated family history at the center of her argument for why she wanted to reinvent her company ...

For CVS, this year has been defined by an unsuccessful fight against elevated medical costs. The third quarter was no different. “We have been more acutely impacted than others in the industry ...